Avagenesis (VVA.V)

Add to Watchlists
Create an Alert
0.72 +0.00  +0.00% TSXV Aug 27, 20:00 Delayed 15m CAD
View Full Chart
VVA.V Price Chart
View All VVA.V News

VVA.V News

  • Wire
    Time (ET)
View All Performance Charts

VVA.V Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Avagenesis is down 61.70% over the last year vs S&P 500 Total Return up 1.46%, Supreme Pharmaceuticals down 61.90%, and MedMira down 33.33%.


VVA.V Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.avagenesis.com
  • HQ Country: Canada
  • HQ State/Province: British Columbia
  • Incorporation Country: Canada
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: September 30, 2015
  • Est. Current Fiscal Year End: June 30, 2016
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: N/A
  • Next Earnings Release: N/A

Avagenesis Corp is a biotechnology company. It is engaged in the development & commercialization of an automated bioprocessing & cell isolation technology for the isolation of regenerative non-fat cells.

VVA.V Excel Add-In Codes

  • Name: =YCI("VVA.V","name")
  • Description: =YCI("VVA.V","description")
  • Sector: =YCI("VVA.V","sector")
  • Industry: =YCI("VVA.V","industry")
  • Est. Current Fiscal Year End: =YCI("VVA.V","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.